Effects of Chronic Administration of Sibutramine on Body Weight, Food Intake and Motor Activity in Neonatally Monosodium Glutamate-Treated Obese Female Rats: Relationship of Antiobesity Effect with Monoamines

Experimental Animals

Volumn 49, Issue 4, 2000, Pages 239-249

  Nakagawa, Terutake ^a   Ukai, Kiyoharu ^a   Ohyama, Tadashi ^a   Gomita, Yutaka ^b   Okamura, Hitoshi ^c  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Body weight; Food intake; Hypothalamic monoamine level; Sibutramine; Spontaneous motor activity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANOREXIGENIC AGENT; BIOGENIC AMINE; CYCLOBUTANE DERIVATIVE; DOPAMINE; GLUTAMATE SODIUM; HOMOVANILLIC ACID; LIPID; NORADRENALIN; SEROTONIN; SIBUTRAMINE;

ADIPOSE TISSUE; ANIMAL; ARCUATE NUCLEUS; ARTICLE; BLOOD; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; DRUG EFFECT; FEMALE; HISTOLOGY; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MOTOR ACTIVITY; NEWBORN; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ADIPOSE TISSUE; ANIMALS; ANIMALS, NEWBORN; APPETITE DEPRESSANTS; ARCUATE NUCLEUS; BIOGENIC MONOAMINES; BODY COMPOSITION; BODY WEIGHT; CYCLOBUTANES; DOPAMINE; ENERGY INTAKE; FEMALE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; LIPIDS; MOTOR ACTIVITY; NOREPINEPHRINE; OBESITY; RATS; SEROTONIN; SODIUM GLUTAMATE; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 0034305638     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.49.239     Document Type: Article

References (46)

1. Baptista, T., Lopez, M.E., Teneud, L., Contreras, Q., Alastre, T., de Quijada, M., Araujo de Baptista, E., Alternus, M., Weiss, S.R., Musseo, E., Paez, X., and Hernandez, L. 1997. Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates. Pharmacopsychiatry 30: 43-54.
2. Bray, G.A. 1985. Autonomie and endocrine factors in the regulation of food intake. Brain Res. Bull. 14: 505-510.
3. Bray, G.A., Ryan, D.H., Gordon, D., Heidingsfelder, S., Cerise, F., and Wilson, K. 1996. A double-blind randomized placebo-controlled trial of sibutramine. Obesity Res. 4: 263-270.
4. Bray, G.A. and York, D.A. 1998. The MONA LISA hypothesis in the time of leptin. Recent. Prog. Horm. Res. 53: 95-117.
5. Buckett, W.R., Thomas, P.C., and Luscome, G.P. 1988. The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog. NeuroPsychopharmacol. Biol. Psychiatry. 12: 575-584.
6. Connoley, I.P., Liu, Y.L., Frost, I., Reckless, I.P., Heal, D.J., and Stock, M.J. 1999. Thermogenic effects of sibutramine and its metabolites. Br. J. Pharmacol. 126: 1487-1495.
7. Cox, C.P. 1967. Continuous-response assay, pp. 105-127. In: Statsistics in endocrinology. (McArthur, J. W. and Colton, T. eds.). THE MIT PRESS, Cambridge.
8. Currie, P.J. and Coscina, D.V. 1997. Stimulation of 5-HT (2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. Neuroreport. 8: 3759-3762.
9. Day, C. and Bailey, C.J. 1998. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice. Int. J. Obes. Relat. Metab. Disord. 22: 619-623.
10. Dulloo, A.G. and Young, J.B. 1991. Effects of monosodium glutamate and gold thioglucose on dietary regulation of sympathetic nervous system activity in rodents. Metabolism 40: 113-121.
11. Edwards, S. and Stevens, R. 1994. Effects of Chronic systemic administration of 5-HT on food intake and body weight in rats. Pharmacol. Biochem. Behav. 47: 865-872.
12. Egawa, M., Yoshimatsu, H., and Bray, G.A. 1991. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260: 328-334.
13. Fletcher, P.J. and Paterson, I.A. 1989. A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus. Pharmacol. Biochem. Behav. 32: 907-911.
14. Ganong, W. F. 1999. Review of Medical Physiology, 19ed. pp. 221-243. Prentice-Hall International Inc., Connecticut.
15. Grignaschi, G., Fanelli, E., Scagnol, I., and Samanin, R. 1999. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats. Br. J. Pharmacol. 127: 1190-1194.
16. Gundlah, C., Martin, K.F., Heal, D.J., and Auerbach, S.B. 1997. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J. Pharmacol. Exp. Ther. 283: 581-591.
17. Heal, D.J., Prow, M.R., and Buckett, W.R. 1991. Effects of antidepressant drugs and electroconvulsive shock on preand postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology (Berl) 103: 251-257.
18. Heal, D.J., Frankland, A.T., Gosden, J., Hutchins, L.J., Prow, M.R., Luscombe, G.P., and Buckett, W.R. 1992. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology (Berl) 107: 303-309.
19. Jackson, H.C., Bearham, M.C., Hutchins, L.J., Mazurkiewicz, S.E., Needham A.M., and Heal, D.J. 1997. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and NA reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol. 121: 1613-1618.
20. Jackson, H.C., Needham, A.M., Hutchins, L.J., Mazurkiewcz, S.E., and Heal, D.J. 1997. Comparison of the Effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol. 121: 1758-1762.
21. Johnston, C.A., Spinedi, E.J., and Negro-Vilar, A. 1984. Effects of neonatal monosodium glutamate (MSG) treatment on the hormonal and central monoaminergic dynamics associated with acute ether stress in the male rat. Brain Res. Bull. 13: 643-649.
22. Karoum, F., Korpi, E.R., Linnoila, M., Chuang, L.W., and Wyatt, R.J. 1984. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments. Eur. J. Pharmacol. 100: 137-144.
23. Leibowitz, S.F. 1978. Paraventricular nucleus: A primary site mediating adrenergic stimulation of feeding and drinking. Pharmacol. Biochem. Behav. 8: 163-175.
24. Leibowitz, S.F. and Rossakis, C. 1979. Mapping study of brain dopamine- and epinephrine-sensitive sites which cause feeding suppression in the rat. Brain Res. 172: 101-113.
25. Leibowitz, S.F., Sladek, C., Spencer, L., and Tempel, D. 1988. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res. Bull. 21: 905-912.
26. Martin, K.F., Phillips, I., Cheetham, S.C., and Heal, D.J. 1995. Dopamine D2 receptors: A potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments. Pharmacol. Biochem. Behav. 51: 565-569.
27. Mousseau, D.D. and Greenshaw, A.J. 1989. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats. J. Neural. Transm. 75: 73-79.
28. Masuda, C., Ukai, K, Kubo, S., and Nakagawa, T. 1989. Effects of BTS54-524 on some experimental amnesia and brain monoamine. Jpn. J. Psychopharmacol. 9: 155 (in Japanese).
29. Mousseau, D.D. and Greenshaw, A.J. 1989. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats. J. Neural. Transm. 75: 73-79.
30. Nakagawa, T., Ukai, K., Ohyama, T., and Koida, M. 1994. Quantative analysis of pharmaco-electroencephalogram using MemCalc system, composed of combination of the maximum entropy method and the non-linear least squares method. pp. 369-382. In: A recent advance in time series analysis by maximum enropy method (Saito, K. eds.), Hokkaido University Press, Sapporo.
31. Nakagawa, T., Ukai, K., Ohyama, T., Koida, M., and Okamura, H. 1996. Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats. Life Sci. 59: 705-712.
32. Nakagawa, T., Ukai, K., Ohyama, T., Gomida, Y., and Okamura, H. 1997. Effect of doperminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats. Pharmacol. Biochem. Behav. 58: 829-836.
33. Nakagawa, T., Ukai, K., and Ueo, H. 1998. Effects of sibutramine on extracellar monoamine concentration in rat hypothalamus and striatum. Exp. Anim. 44 (Suppl.): 162 (in Japanese).
34. Nemeroff, C. B., Grant, L.D., Bissette, G., Ervin, G. N., Harrell, L.E., and Prange, Jr. A.J. 1977. Growth, endocrinological and behavioral deficits after monosodium L-glutamate in the neonatal rat: Possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology 2: 179-196.
35. Nemeroff, C.B., Konkol, R.J., Bissette, G., Youngblood, W., Martin, J.B., Brazeau, P., Rone M.S., Prange, Jr. A.J., Breese, G.R., and Kizer, J.S. 1977. Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopamincrgic systems in neuroendocrine regulation. Endocrinology 101: 614-622.
36. Oida, K., Nakai, T., Hayashi, T., Miyabo, S., and Takeda, R. 1984. Plasma lipoproteins of monosodium glutamate-induced obese rats. Int. J. Obes. 8: 385-391.
37. Paez, X. and Leibowitz, S.F. 1993. Changes in extracellular PVN monoamines and macronutrient intake after idazoxan or fluoxetine injection. Pharmacol. Biochem. Behav. 46: 933-941.
38. Sakaguchi, T. and Bray, G.A. 1989. Effect of norepinephrine, serotonin and tryptophan on the firing rate of sympathetic nerves. Brain Res. 492: 271-280.
39. Stricker-Konggrad, A., Souquet, A.M., and Burlet C. 1995. Effects of sibutramine on feeding behaviour dietary-induced obesity: Role of dietary constituents. Int. J. Obes. 19 (Suppl. 2): 398.
40. Stricker-Konggrad, A., Souquet, A.M., and Burlet C. 1995. Effects of sibutramine on feeding behaviour in obese and lean Zucker rats. Int. J. Obes. 19 (Suppl 2): 399.
41. Weiser, M., Frishman, W.H., Michaelson, M.D., and Abdeen, M.A. 1997. The pharmacologic approach to the treatment of obesity. J. Clin. Pharmacol. 37: 453-473.
42. Weiss, G.F., Papadakos, P., Knudson, K., and Leibowitz, S.F. 1986. Medial hypothalamic serotonin: Effects on deprivation and norepinephrine-induced eating. Pharmacol. Biochem. Behav. 25: 1223-1230.
43. Williams, T., Berelowitz, M., Joffe, S.N., Thorner, M.O., Rivier, J., Vale, W., and Frohman, L.A. 1984. Impaired growth hormone responses to growth hormone-releasing factor in obesity. N. Engl. J. Med. 311: 1403-1407.
44. Wortley, K.E., Heal, D.J., and Stanford, S.C. 1999. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. Br. J. Pharmacol. 128: 659-666.
45. Yoshida, T., Yoshioka, K., Hiraoka, N., and Kondo, M. 1990. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice. J. Nutr. Sci. Vitaminol (Tokyo) 36: 123-130.
46. Zhang, W.M., Kuchar, S. K., and Mozes, S. 1994. Body Fat and RNA content of the VMH cells in rats neonatally treated with monosodium glutamate. Brain Res. Bull. 35: 383-385.